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Injuries When Handling Micotil 300®
Summary
Livestock producers, veteri­
narians, and other workers 
may be exposed to the toxic 
hazards of the animal antibiotic 
Micotil 300® through needle- 
stick injuries, skin cuts, punc­
ture wounds, and contact with 
skin and mucous membranes. 
Cardiotoxic effects of Micotil 
300® on the human heart, in­
cluding a reduced cardiac con­
tractility and tachycardia (rap­
id heart beat), can be severe 
enough to cause death.
The National Institute for Oc­
cupational Safety and Health 
(NIOSH) recommends that 
extreme care be given to fol­
lowing safe drug handling and 
injection procedures to avoid 
the possibility of self injec­
tion. Although no antidote ex­
ists for Micotil 300®, exposed 
persons should seek imme­
diate medical intervention as 




Tilmicosin phosphate, sold under the 
trade nam e Micotil 300®, is an animal 
antibiotic developed to  trea t “shipping 
fever,” a bovine and ovine respiratory 
disease. In th e  U nited States, veterinar­
ians give Micotil 300® to  animals, b u t 
m ore frequently  prescribe it for the ir 
clients to  use on cattle  and sheep at 
livestock facilities.
T he 2002  C ensus o f A gricu ltu re re ­
p o r te d  80 ,743  U .S . farm s w ith  c a t­
tle  feed  operations involving 14.9 
m illion  head  of ca ttle  [U S D A  2004]. 
T housands of w orkers on  th e se  farm s 
could  be exposed  w h en  th e y  in ject 
ca ttle  w ith  M icotil 3 0 0 ®.
Elanco, th e  com pany th a t developed 
and produces M icotil 300®, received 
2,392 reports of hum an exposures 
w orldw ide to  M icotil 300® betw een  
1992 and 2000 [Elanco 2002]. Thir­
te e n  confirm ed M icotil 300®-associ- 
ated  hum an fatalities have been  re ­
corded w orldw ide since 1995, m ost 
associated w ith  suicides [FDA 2006].
Case Studies
T he N ebraska Fatality A ssessm ent 
and C o n tro l Evaluation Program  (NE 
FACE) investigated  tw o  separate  in ­
c iden ts involving un in ten tio n a l in jec­
tio n  o f M icotil 3 0 0 ®.
Case 1
O n  M arch 8, 2003, a 38-year-old ca t­
tlem an  was preparing to  inject M icotil 
300® into a heifer secured in  a squeeze 
chute inside a barn. The cattlem an was 
carrying a 12-cc plastic disposable sy­
ringe in his right hand. The m an was 
knocked to  th e  ground w hen  a cow  in 
an adjacent pen  charged, striking the  
fence panel. As a result o f e ither the  
strike or th e  fall, th e  cattlem an was 
injected w ith  an unknow n am ount of 
th e  antibiotic. H e im m ediately began 
to  feel dizzy and nauseated. H e was 
able to  call for help, and his wife, in 
th e  house nearby, called an am bulance. 
The victim  was rushed to  a nearby hos­
pital w here he died an hour and a half 
later. The dea th  certificate indicated 
th e  cause of death  w as respiratory fail­
u re as a consequence of cardiac arrest 
caused by a lethal injection [Nebraska 
D epartm en t o f Labor 2003].
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Case 2
O n  N ovem ber 16, 2004 , a 41-year-old  ca ttle  rancher was 
p reparing  to  in jec t tw o  calves w ith  M icotil 3 0 0 ® using a 
20-cc p lastic disposable syringe. T he calves w ere  in  an 
ou tside lo t squeeze chute. A fter in jecting  th e  first calf, 
th e  ran ch er p laced  th e  syringe in  his m o u th  to  ho ld  it, 
freeing his hands to  o pen  th e  squeeze ch u te  gate. A t th e  
sam e instan t, th e  in jec ted  calf lunged forw ard , flinging 
open  th e  end  doors and causing th e  hand le to  strike  th e  
v ic tim ’s le ft hand , driving it backw ards in to  th e  needle . 
T he rancher w as in jec ted  b e tw e e n  his le f t th u m b  and 
first finger w ith  1 to  1.5 cc o f M icotil 300®. H e im m ed i­
ately  fe lt a burn ing  sensation  at th e  in jection  site. W ith in  
a few  m inu tes, he developed  a severe ringing in  his ears 
and fe lt as th o u g h  his tongue and lips w ere  sw ollen. H e 
called o u t for help , and his w ife called th e  Rocky M o u n ­
ta in  Poison C o n tro l C en ter. T hey  advised h er to  place 
ice on th e  in jection  site and im m ed ia te ly  get h er h u s­
b and  to  an em ergency room . As his cond ition  w orsened  
in  th e  em ergency d ep a rtm en t, he w as airlifted  to  a re ­
gional m edical cen te r and tre a te d  in  th e  in tensive care 
u n it for 2 days. A fter his cond ition  stabilized, he w as d is­
charged [N ebraska D e p a rtm e n t o f Labor 2005].
Controls
W orkers and em ployers should  tak e  th e  follow ing steps 
to  p ro te c t them selves and o thers  w h en  handling or ad ­
m in istering  M icotil 300®. In th e  case of h u m an  injection, 
consu lt a physician  im m ed ia te ly  and  apply  ice to  th e  in ­
je c tio n  site . T ranspo rt th e  v ic tim  im m ed ia te ly  to  a hos­
p ita l and call 1 -8 0 0 -7 2 2 -0 9 8 7  for fu rth e r  em ergency in ­
form ation .
Veterinarians
■ C onsider prescrib ing anim al m ed ica tions th a t  do not 
have tox ic effec ts  on hum ans.
■ D o n o t adm in ister M icotil 3 0 0 ® if anim als canno t be 
restra in ed  in  an ap p ro p ria te  restra in t, or if th e re  is 
concern  over o p era to r skill.
■ U sing th e  c lien t in fo rm atio n  sh e e t a tta c h e d  to  each  
b o ttle  o f M ico til 300®, verbally  rev iew  E lanco’s r e ­
v ised  u se r safe ty  w arnings w ith  each  purchaser. U se 
a co-signed M ico til 300® C lient Dispensing In form a­
tion  fo rm  [Elanco 2006] to  d o cu m e n t th a t  each  p u r­
chaser u n d e rs ta n d s  th a t  M ico til 300® has b e e n  fatal 
to  hum ans. T his fo rm  details th e  hazards associa ted  
w ith  M ico til 300® and iden tifies safe ad m in istra tio n  
m e th o d s, ap p rop ria te  first aid tre a tm e n t, and em er­
gency phone num bers.
■ Provide guidance to  purchasers on p ro p er eq u ip m en t 
for adm in istra tion . M u ltip le  dose d ispensers are avail­
able and include specific handling instructions.
Employers
■ S to re  M icotil 3 0 0 ® in a safe location  th a t  is n o t read i­
ly accessible by u n tra in ed  persons.
■ Train w orkers assigned to  handle M icotil 300® by using 
training videos, DVDs, lam inated dosage sheets, m ateri­
al safety data  sheets (M SD S), client inform ation sheet, 
and safe handling cards. To obtain these materials, call 
Elanco at 1 -8 0 0 -4 2 8 -4 4 4 1  or visit Elanco’s W eb site at 
www. elanco. com .
■ E nsure th a t  p ro p er handling p ro ced u res  for M icotil 
300® are available at th e  w orksite  and are rev iew ed by 
all w orkers befo re  th e y  hand le th is  drug. T hese p ro ­
cedures should  be w ritte n  in  th e  prim ary  language(s) 
of drug hand lers and a t th e ir  reading level.
■ Provide a m eans to  adequate ly  restra in  anim als d u r­
ing tre a tm e n t. A n anim al th a t  is adequate ly  restra in ed  
w ill n o t be able to  m ove in  an un p red ic tab le  m anner. 
W ork w ith  a veterinarian  to  d e te rm in e  w h a t adequate  
re s tra in t m eans for th e  particu la r operation .
■ Provide a sharps disposal con ta iner for safe handling 
and disposal of syringes and needles, and goggles and 
im perm eable, need le -punctu re-resistan t gloves for p er­
sonal p ro tection .
■ Ensure th a t only persons tra ined  in th e  hazards of M i­
cotil 300® and safe handling p rocedures are allow ed to  
handle th is drug and th a t w orkers do n o t w ork  alone 
w hile handling or injecting th e  drug.
■ E nsure th a t  coldpacks and icepacks are available at 
th e  w orkplace w here  in jections w ill be given.
■ E nsure th a t  te lep h o n es are available to  w orkers. Post 
th e  follow ing te lep h o n e  num bers in  visible locations 
such as near th e  office, barn , and house te lephones:
—  E m ergency M edical Services
911 or dial 0 (operato r) and re p o rt th e  em er­
gency and specific location
—  Rocky M ountain Poison C ontro l and D rug C en ter 
1 -8 0 0 -3 3 2 -3 0 7 3  (This cen ter has been  trained 
by th e  drug m anufacturer to  handle em ergencies 
specific to  M icotil 300® exposure in  b o th  English 
and Spanish)
—  Elanco: 1 -8 0 0 -7 2 2 -0 9 8 7 , m edical em ergency 
ho tline; 1 -8 0 0 -4 2 8 -4 4 4 1  (English only)
Workers
Drug handling and preparation
■ Read, u n d erstan d , and follow  all d irec tions loca ted  on 
th e  label and on th e  c lien t in fo rm ation  shee t th a t  is 
prov ided  w ith  each b o ttle  o f M icotil 3 0 0 ®.
■ W ear goggles an d  im p e rm e a b le , n e e d le -p u n c tu re -  
res is tan t gloves, and w ash  hands afte r handling.
■ N ever w ork  alone w h en  handling  or in jecting  M icotil 
3 0 0 ®.
■ Fill syringes in  an area restric ted  for th a t purpose alone 
(preparation  room ). N ever allow children  in th is area.
■ D o n o t sm oke, eat, drink , or sto re food in  th e  restic t- 
ed area.
■ N ever use autom atically  po w ered  syringes.
■ N ever fill one syringe w ith  m ed ica tion  for in jecting  
several anim als. U se a separate  syringe for each ani­
m al. If p rov ided  w ith  a m u ltip le  dose dispenser, ask 
em ployer for specific handling instructions.
■ Always use a 16- to  18-gauge need le  th a t  is 1 /2  inch 
to  5 /8  inches long.
■ Keep a pro tec tive cover on needles un til ready for use.
■ Place filled syringes in  a p u n c tu re -p ro o f carrying case 
befo re  m oving to  th e  an im al’s location.
■ N ever place or carry a loaded  syringe in  a pocket, o th ­
er clothing, or in  th e  m outh .
■ C lean  u p  spills im m ediately.
■ Call one o f th e  em ergency con tac t num bers if an ex ­
posure occurs, apply ice, p ro ceed  im m ed ia te ly  to  a 
hosp ital em ergency room , or call 911 for em ergency 
tran sp o rt.
Injection o f livestock
■ K eep ch ild ren  and bystanders o u t o f th e  area w here  
M icotil 3 0 0 ® is to  be given.
■ W ear goggles an d  im p e rm e a b le , n e e d le -p u n c tu re -  
res is tan t gloves, and w ash hands afte r handling.
■ Evaluate th e  anim al to  b e  in jec ted  as w ell as th e  ani­
m a l’s surroundings to  d e te rm in e  w h e th e r  it is safe to  
give th e  drug.
■ D o n o t give th e  drug to  an anim al th a t  canno t b e  ad e­
quately  restra ined .
■ R estrain anim als in  a re s tra in t th a t  th e  em ployer, in 
consu lta tion  w ith  th e  veterinarian , has d e te rm in e d  is 
adequate  for th e  operation .
■ Iden tify  a useable ex it ro u te  in  case th e  anim al breaks 
o u t o f th e  restra in t.
■ In jec t M icotil 300® by holding th e  syringe in  one hand  
w hile  inserting  th e  need le  subcutaneously  and at a 
to p -d o w n  angle. Avoid p en e tra tin g  th e  an im al’s u n ­
derlying m uscle.
■ D o n o t rep lace  th e  p ro tec tiv e  cap over th e  need le  of 
th e  syringe afte r use.
■ Im m ediate ly  afte r use, place th e  syringe w ith  need le  
a ttac h ed  in  a p u n c tu re -p ro o f sharps disposal con ta in ­
er. R e tu rn  th e  disposal con ta iner to  th e  p rep a ra tio n  
area for final disposal.
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For More Information
For more information about intervention after human expo- ]
sure to  injected Micotil 300®, contact Elanco Animal Health, a 
Division of Eli Lilly & Company: P.O. Box 707, 2001 W  Main 
St., Greenfield, IN 46140; telephone 1-800-722-0987. !
For Micotil 300® safe handling and use materials, visit the [
Elanco Web site at www.elanco.com. \
The information in this document is based on fatality inves­
tigations, literature, and expert review. More information 
about the Fatality Assessment and Control Evaluation Pro­
gram is available at w w w .cdc .gov /n iosh /face . !
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NIOSH eNews by visiting www.cdc.gov/niosh/eNews.
Mention of any company or product does not constitute en­
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